Skip to main content

Table 2 Performance of patients assigned to either the Saudi initiative for asthma or Global initiative for asthma approaches after treatment initiation

From: Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: a randomized controlled trial

Characteristics

SINAagroup

GINAb group

p-value

Forced expiratory volume in 1 second

   

- First visit--No. (± SD)

81.4% (± 17.1%)

84.3% (± 16.2%)

0.269

- Follow-up visit--No. (± SD)

87.2 (± 14.7%)

87.7 (± 17.6)

0.697

- Difference between two visits--No. (± SD)

5.8% (± 12.8)

3.4% (± 13.9)

0.46

Peak flow meter

   

- First visit--No. (± SD)

343.1 (± 129.3)

362.9 (± 148.8)

0.503

- Follow-up visit--No. (± SD)

389 (± 120.5)

423.1 (± 116.6)

0.182

- Difference between two visits--No. (± SD)

46.84 (63.3%)

60.7 (± 77.8)

0.803

Asthma control test score

   

- First visit--No. (± SD)

17.6 (± 4.5)

17.8 (± 3.6)

0.776

- Follow-up visit--No. (± SD)

20.5 (± 3.5)

19.5 (± 3.3)

0.43

- Difference between two visits--No. (± SD)

2.9 (± 3.1)

1.7 (± 2.9)

0.04

  1. a SINA: Saudi Initiative for Asthma; b GINA: Global Initiative for Asthma